Curating evidence for a cure of HIV-1 infection by hematopoietic stem cell transplantation.
Journal
Med (New York, N.Y.)
ISSN: 2666-6340
Titre abrégé: Med
Pays: United States
ID NLM: 101769215
Informations de publication
Date de publication:
12 05 2023
12 05 2023
Historique:
received:
14
04
2023
revised:
17
04
2023
accepted:
18
04
2023
medline:
15
5
2023
pubmed:
14
5
2023
entrez:
13
5
2023
Statut:
ppublish
Résumé
A cure of HIV-1 infection has previously been described in two individuals undergoing allogeneic hematopoietic stem cell transplants from homozygous carriers of the CCR5Δ32 gene variant, which confers HIV-1 resistance. Two recent reports corroborate these earlier studies, underscoring that in HIV-1-infected persons with hematologic malignancies, these procedures may provide a realistic perspective for a cure of HIV-1 infection.
Identifiants
pubmed: 37178680
pii: S2666-6340(23)00138-1
doi: 10.1016/j.medj.2023.04.006
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
285-287Subventions
Organisme : NIAID NIH HHS
ID : UM1 AI164560
Pays : United States
Commentaires et corrections
Type : CommentOn
Type : CommentOn
Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interest The authors declare no competing interests.